Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Summary

Anika Therapeutics (NASDAQ: ANIK) granted restricted stock units covering 3,360 common shares to a newly hired non-executive employee, effective June 1, 2026.

The award, issued under the 2021 Inducement Plan and Nasdaq Listing Rule 5635(c)(4), vests in three equal annual installments over three years, contingent on continuous service.

AI-generated analysis. Not financial advice.

Key Figures

RSU grant size: 3,360 shares Vesting schedule: 3 equal installments Plan year: 2021 Inducement Plan

3 metrics

RSU grant size 3,360 shares Inducement grant to one newly hired non-executive employee on June 1, 2026

Vesting schedule 3 equal installments RSUs vest on each of the first three anniversaries of grant date

Plan year 2021 Inducement Plan Equity granted under Anika Therapeutics, Inc. 2021 Inducement Plan, as amended

Market Reality Check

Price: $14.81 Vol: Volume 30,936 is below th...

low vol

$14.81 Last Close

Volume Volume 30,936 is below the 20-day average of 72,655, suggesting limited pre-news trading interest. low

Technical Price $14.46 is trading above the 200-day MA $11.30, reflecting a generally improving trend before this filing.

Peers on Argus

ANIK was up 2.64% while key peers like CTOR, DERM, INCR, and IRWD showed decline...

1 Down

ANIK was up 2.64% while key peers like CTOR, DERM, INCR, and IRWD showed declines between about 1–3%. Momentum scanner only flagged INCR moving down, indicating ANIK’s move was more stock-specific than sector-driven.

Historical Context

5 past events · Latest: Apr 29 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Apr 29	Q1 2026 earnings	Positive	-18.8%	Reported Q1 revenue growth, margin expansion, positive adjusted EBITDA, and reaffirmed guidance.
Apr 15	Earnings preview	Neutral	+0.7%	Announced timing and access details for upcoming Q1 2026 earnings release and call.
Apr 03	Inducement RSU grant	Neutral	-0.3%	Granted 3,138 RSUs to a new employee under Nasdaq inducement rules.
Feb 26	Q4/FY 2025 earnings	Positive	+16.9%	Reported Q4 margin expansion, cash generation, 2026 guidance, and ongoing repurchase program.
Feb 18	Conference presentation	Neutral	+1.7%	Announced CEO presentation and investor meetings at a musculoskeletal conference.

Pattern Detected

Earnings and corporate updates have produced mixed reactions, including one sharp selloff on otherwise positive Q1 2026 metrics.

Recent Company History

Over the last few months, Anika has focused on financial execution and capital returns. Q4 2025 and full‑year results on Feb 26 showed stable revenue and expanding margins with a strong positive price reaction. The Q1 2026 report on Apr 29 delivered $29.6M revenue and improved gross margin, but the stock fell sharply afterward. Routine items such as conference participation and prior inducement RSU grants had minimal price impact, framing today’s RSU grant as another ordinary-course compensation event.

Market Pulse Summary

This announcement details a routine compensation action: an inducement grant of 3,360 restricted sto...

Analysis

This announcement details a routine compensation action: an inducement grant of 3,360 restricted stock units to a new non-executive employee under the 2021 Inducement Plan, vesting in three annual installments. Similar RSU grants in April 2026 had minimal price impact. Recent filings also show active insider purchases and an ongoing focus on operational improvement. Investors may track future earnings, cash levels, and additional equity awards for signals on dilution and corporate direction.

Key Terms

restricted stock units, nasdaq listing rule 5635(c)(4), equity award

3 terms

restricted stock units financial

"Anika granted restricted stock units (“RSUs”) covering an aggregate of 3,360 shares..."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

nasdaq listing rule 5635(c)(4) regulatory

"in accordance with Nasdaq Listing Rule 5635(c)(4), was made as a material inducement..."

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

equity award financial

"The RSUs are subject to the terms and conditions of the equity award agreement..."

An equity award is a form of pay where a company gives employees, executives or other stakeholders the right to own or buy company shares—either immediately or after meeting certain conditions. Think of it like receiving slices of the company pie now or coupons to claim slices later; it matters to investors because it affects ownership dilution, executive incentives and reported compensation costs, and signals how management is being rewarded and retained.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on June 1, 2026, Anika granted restricted stock units (“RSUs”) covering an aggregate of 3,360 shares of common stock to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), was made as a material inducement to the grantee’s acceptance of employment with Anika as a component of the grantee’s employment compensation.

The RSUs will vest in three equal installments on each of the first three anniversaries of the grant date, in each case for so long as the grantee provides continuous service to Anika through the relevant vesting date.

The RSUs are subject to the terms and conditions of the equity award agreement approved by Anika. The RSUs were granted pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, which was not subject to stockholder approval.

About Anika

Anika Therapeutics, Inc. (NASDAQ: ANIK), is the global leader in the design, development, manufacturing, and commercialization of hyaluronic acid innovations. In partnership with clinicians, our sole focus is dedicated to delivering and advancing osteoarthritis pain management and orthopedic regenerative solutions. At our core is a passion to deliver a differentiated portfolio that improves patient outcomes around the world. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.

For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com

FAQ

What inducement grant did Anika (NASDAQ: ANIK) announce on June 5, 2026?

Anika announced restricted stock units covering 3,360 shares for a newly hired non-executive employee. According to Anika, the award was granted on June 1, 2026 as a material inducement to the employee’s acceptance of employment under its 2021 Inducement Plan.

How many shares are covered by Anika’s June 2026 inducement RSU grant (ANIK)?

The inducement grant covers 3,360 shares of Anika common stock. According to Anika, these shares are delivered as restricted stock units that vest over three years, subject to the employee’s continued service with the company through each applicable vesting date.

What are the vesting terms of the new Anika (ANIK) inducement RSUs granted June 1, 2026?

The RSUs vest in three equal annual installments on each of the first three anniversaries of June 1, 2026. According to Anika, vesting requires the grantee to provide continuous service to the company through each relevant vesting date under the equity award agreement.

Under which plan were Anika’s June 2026 inducement RSUs granted?

The RSUs were granted under the Anika Therapeutics 2021 Inducement Plan, as amended. According to Anika, this plan was used specifically for inducement awards and was not submitted for stockholder approval, consistent with Nasdaq Listing Rule 5635(c)(4) requirements for such grants.

How does Nasdaq Listing Rule 5635(c)(4) relate to Anika’s June 2026 RSU grant (ANIK)?

The grant was structured as a material inducement to employment in line with Nasdaq Listing Rule 5635(c)(4). According to Anika, this rule allows equity awards to new employees outside stockholder-approved plans when used as a material inducement to join the company.

Who received the June 1, 2026 inducement RSU grant from Anika (ANIK)?

The RSUs were granted to one newly hired non-executive employee of Anika. According to Anika, the equity award forms part of the employee’s overall compensation package and is subject to the terms and conditions of an approved equity award agreement.